Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

The role of oxidative stress on cardiovascular disease in metabolic syndrome: Efficacy and safety of EGCG and CGA

Heart Science Journal · Vol. 7 No. 1 (2026) · pp. 11–16

DOI
10.21776/ub.hsj.2026.007.01.3
ISSN
2721-9984, 2721-9976
Published
2026-01-31
Publisher
Universitas Brawijaya
Language
en
License
creativecommons.org/licenses/by/4.0

Abstract

The challenge of cardiovascular disease has spread across the globe, especially concerning metabolic syndrome and its components. There is a need to look for new treatment strategies that attack underlying pathophysiological mechanisms. This review discusses the role of oxidative stress in the development and progression of cardiovascular complications in metabolic syndrome while evaluating the therapeutic potential of two natural compounds as antioxidants: epigallocatechin gallate (EGCG) from green tea and chlorogenic acid (CGA) from coffee. Oxidative stress disrupts normal cellular function through multiple pathways, including LDL oxidation, nitric oxide function, glycolysis, modified TCA cycle activity, and activation of inflammatory cascades. These mechanisms contribute to CVD's endothelial dysfunction, atherosclerosis, and cardiac remodelling. Despite its limited bioavailability and concentration-dependent effects, EGCG demonstrates significant cardiovascular benefits through enhanced NO bioavailability, activation of antioxidant pathways, and suppression of inflammatory responses. CGA shows promising results in hypertension management and endothelial function improvement, with clinical studies reporting significant blood pressure reductions and improved vascular function. These natural compounds could serve as valuable add-on therapeutic agents for treating cardiovascular disease associated with metabolic syndrome. However, optimal dosing strategies and individual patient factors require further investigation

Keywords

Collaboration network of the authors

40 authors · 282 co-authorship links · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • University of Brawijaya
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Cholid Tri TjahjonoUniversity of Brawijaya20
Anna Fuji RahimahUniversity of Brawijaya18
Ardian RizalUniversity of Brawijaya18
Budi SatrijoUniversity of Brawijaya17
Indra PrasetyaUniversity of Brawijaya17
Setyasih AnjarwaniUniversity of Brawijaya17
Novi KurnianingsihUniversity of Brawijaya15
Yoga WaranugrahaUniversity of Brawijaya9
Djanggan SargowoUniversity of Brawijaya9
Sasmojo WiditoUniversity of Brawijaya9
Heny MartiniUniversity of Brawijaya9
Adhika Prastya WikanandaUniversity of Brawijaya4
Tri AstiawatiUniversity of Brawijaya4
Wella KarolinaUniversity of Brawijaya4
Putri Annisa KamilaUniversity of Brawijaya3
Dadang HendrawanUniversity of Brawijaya3
Muhammad Rizki FadlanUniversity of Brawijaya3
Fandy HazzyUniversity of Brawijaya3
Hayla Iqda MillisaniUniversity of Brawijaya3
Oktivani Adelathifa RahmaUniversity of Brawijaya3
Veny KurniawatiUniversity of Brawijaya2
Tonny AdriyantoUniversity of Brawijaya2
Jonny Karunia FajarUniversity of Brawijaya2
Olivia HandayaniUniversity of Brawijaya2
Fahmy RusnantaUniversity of Brawijaya2
Fitranti Suciati LaitupaUniversity of Brawijaya2
Oktafin Srywati PamunaUniversity of Brawijaya2
Anna Fuji RahimahAffiliation unknown2
Imelda KrisnasariUniversity of Brawijaya2
Ratna PancasariUniversity of Brawijaya2
Ayu Asri Devi AdityawatiUniversity of Brawijaya2
Krishna Ari NugrahaUniversity of Brawijaya2
Seprian WidasmaraUniversity of Brawijaya2
Pawik SupriadiUniversity of Brawijaya2
Wira KimahesaUniversity of Brawijaya2
Valerinna YogibuanaAffiliation unknown2
Cik KahadiUniversity of Brawijaya2
Fahreza CaesarioUniversity of Brawijaya2

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, first harvested 8 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The role of oxidative stress on cardiovascular disease in metabolic syndrome: Efficacy and safety of EGCG and CGA</dc:title>
	<dc:creator xml:lang="en">Nugroho, Ira Vori</dc:creator>
	<dc:creator xml:lang="en">Rohman, Mohammad Saifur</dc:creator>
	<dc:subject xml:lang="en">Cardiovascular Disease</dc:subject>
	<dc:subject xml:lang="en">Metabolic Syndrome</dc:subject>
	<dc:subject xml:lang="en">Oxidative Stress</dc:subject>
	<dc:subject xml:lang="en">Antioxidants</dc:subject>
	<dc:subject xml:lang="en">Epigallocatechin Gallate (EGCG)</dc:subject>
	<dc:subject xml:lang="en">Chlorogenic Acid (CGA).</dc:subject>
	<dc:description xml:lang="en">The challenge of cardiovascular disease has spread across the globe, especially concerning metabolic syndrome and its components. There is a need to look for new treatment strategies that attack underlying pathophysiological mechanisms. This review discusses the role of oxidative stress in the development and progression of cardiovascular complications in metabolic syndrome while evaluating the therapeutic potential of two natural compounds as antioxidants: epigallocatechin gallate (EGCG) from green tea and chlorogenic acid (CGA) from coffee. Oxidative stress disrupts normal cellular function through multiple pathways, including LDL oxidation, nitric oxide function, glycolysis, modified TCA cycle activity, and activation of inflammatory cascades. These mechanisms contribute to CVD's endothelial dysfunction, atherosclerosis, and cardiac remodelling. Despite its limited bioavailability and concentration-dependent effects, EGCG demonstrates significant cardiovascular benefits through enhanced NO bioavailability, activation of antioxidant pathways, and suppression of inflammatory responses. CGA shows promising results in hypertension management and endothelial function improvement, with clinical studies reporting significant blood pressure reductions and improved vascular function. These natural compounds could serve as valuable add-on therapeutic agents for treating cardiovascular disease associated with metabolic syndrome. However, optimal dosing strategies and individual patient factors require further investigation</dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2026-01-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20291</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2026.007.01.3</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 7 No. 1 (2026): Accelerating Clinical Breakthroughs: The Journey from Molecular Discovery to Patient Care; 11-16</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2026.007.01</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20291/549</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Ira Vori, Mohammad Saifur Rohman</dc:rights>
	<dc:rights xml:lang="en">http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>